- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Oliver Dorigo Discusses an Interdisciplinary Approach to Care in Gynecologic Oncology
An interdisciplinary approach to patient care is very important because the treatment of gynecologic cancers can be very complex, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.
An interdisciplinary approach to patient care is very important because the treatment of gynecologic cancers can be very complex, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.
Transcript
How does your division at Stanford utilize an interdisciplinary approach to patient care?
An interdisciplinary approach to patient care, in my opinion, is very important since the treatment of gynecologic cancers can be very complex. Our patients are seen initially in our clinic, but upon diagnosis, they are then treated by an interdisciplinary team that does include the gynecologic oncologist, the radiation oncologist, radiologist, pathologist, and the palliative care service.
We nowadays believe that palliative care is a very important aspect of gynecologic cancer care from the very first beginning since we want to help patients with the diagnosis, the psychological aspect of having been diagnosed with cancer, and also side effects that are related to the treatment.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Phase 1 Study Identifies Casdatifan Dose With Promising Responses in Pretreated Clear Cell RCC
February 18th 2025Casdatifan targets a transcription factor that binds with other proteins to switch off the body’s anti-inflammatory mechanisms, empowering genes that promote tumor growth in clear cell renal cell carcinoma (RCC).
Read More
